Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, 466-8550, Japan.
British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Ann Nucl Med. 2023 Aug;37(8):451-461. doi: 10.1007/s12149-023-01838-9. Epub 2023 Jun 5.
Delayed heart-to-mediastinum ratio (HMR) has been associated with catecholamine levels and contractile reserve in dilated cardiomyopathy (DCM); however, there is scant evidence regarding the association between cardiac sympathetic activity and left ventricular reverse remodeling (LV-RR). We calculated the I-metaiodobenzylguanidine (I-mIBG) HMR and washout rate (WR) in patients with DCM and investigated their associations with LV-RR.
From April 2003 to January 2020, in 120 patients with DCM who underwent I-mIBG scintigraphy. 66 patients undergoing follow-up echo and taking a beta-blocker from baseline were examined the relationship between I-mIBG and LV-RR. After that, this prognostic value for composite cardiac events was evaluated in the entire 120 patients.
In LV-RR analysis, patients were 50.4 ± 12.2 years, with a mean left ventricular ejection fraction of 28.6%. Of 66 patients, 28 (42.4%) achieved LV-RR. Multiple logistic regression analysis of LV-RR revealed that not delayed HMR but the WR (cutoff value: 13.5%) was an independent predictor of LV-RR (odds ratio 6.514, p = 0.002). In the analysis for composite cardiac events, even though WR itself does not have the prognostic capacity, Kaplan-Meier survival curves divided by the cutoff value (delayed HMR = 2.0, WR = 13.5) showed that delayed HMR and WR values enabled the stratification of high-risk patients (log-rank p < 0.001).
The I-mIBG WR was associated with the prevalence of LV-RR in patients taking 100% of beta-blockers and 98.5% of renin-angiotensin system inhibitors. Reflecting the contractile reserve, the combined assessment of the delayed HMR and WR could be used to further precisely stratify the patients with DCM.
心脏与纵隔比值(HMR)延迟与扩张型心肌病(DCM)中的儿茶酚胺水平和收缩储备有关;然而,关于心脏交感神经活性与左心室逆重构(LV-RR)之间的关联,证据很少。我们在 DCM 患者中计算了 I-间碘苄胍(I-mIBG)HMR 和洗脱率(WR),并研究了它们与 LV-RR 的关系。
2003 年 4 月至 2020 年 1 月,对 120 例接受 I-mIBG 闪烁显像的 DCM 患者进行研究。对 66 例从基线开始接受超声心动图随访并服用β受体阻滞剂的患者进行检查,以了解 I-mIBG 与 LV-RR 的关系。之后,在 120 例患者中评估了该指标对复合心脏事件的预后价值。
在 LV-RR 分析中,患者年龄为 50.4±12.2 岁,左心室射血分数平均为 28.6%。在 66 例患者中,28 例(42.4%)达到了 LV-RR。LV-RR 的多因素逻辑回归分析显示,不是延迟的 HMR,而是 WR(临界值:13.5%)是 LV-RR 的独立预测因子(比值比 6.514,p=0.002)。在复合心脏事件分析中,尽管 WR 本身没有预后能力,但根据临界值(延迟 HMR=2.0,WR=13.5)绘制的 Kaplan-Meier 生存曲线表明,延迟 HMR 和 WR 值可以对高危患者进行分层(对数秩检验 p<0.001)。
在服用 100%β受体阻滞剂和 98.5%肾素-血管紧张素系统抑制剂的患者中,I-mIBG WR 与 LV-RR 的发生率有关。反映收缩储备的情况,延迟 HMR 和 WR 的联合评估可用于进一步准确分层 DCM 患者。